MedTrace Logo

Effect of Combined Intravenous-Inhalational Anesthesia (CIVIA) on Postoperative Recovery Patterns.

NCT07123870 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2025-08-14

No results posted yet for this study

Summary

This study was planned as a single-center, prospective, randomized trial. Adult patients undergoing elective spinal surgery lasting longer than three hours, performed in a neurosurgery operating room, will be evaluated. Patients managed with three different anesthesia methods currently used will be examined for recovery patterns:

1. Total intravenous anesthesia (TIVA),
2. TIVA Combined anesthesia with sevoflurane and intravenous agents (sevoflurane-CIVIA),
3. TIVA Combined anesthesia with desflurane and intravenous agents (desflurane-CIVIA).

Recovery patterns include; extubation time, eye opening time, emergence agitation, postoperative nausia and vomiting and postoperative recovery unit discharge time.

Conditions

  • Postoperative Recovery
  • Inhalation Anesthesia
  • Total Intravenous Anesthesia

Interventions

DRUG

Sevofluorane

In this group of patients, \<0.5 MAC sevoflurane will be used in combination with TIVA. (TIVA method described above)

DRUG

Desflurane

In this group of patients, \<0.5 MAC Desflurane will be used in combination with TIVA.

DRUG

Total Intravenous Anesthesia(TIVA)

In this group, TIVA will be applied with the combination of BIS-guided propofol + remifentanil.

Sponsors & Collaborators

  • Kocaeli City Hospital

    lead OTHER_GOV

Principal Investigators

  • Ahmet YUKSEK, Md · Kocaeli City Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-23
Primary Completion
2025-10-29
Completion
2025-11-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07123870 on ClinicalTrials.gov